Rapid progress in molecular targeted therapy for allergic diseases
Allergology International · 2023
DOI: 10.1016/j.alit.2022.11.011 ↗Kurz gefasst
Editorial in der Zeitschrift Allergology International, 2023. Verfasst von Hiroyuki Nagase. Beteiligte Einrichtung: Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8…. Hauptthemen laut MEDLINE: Molecular Targeted Therapy, Hypersensitivity. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8606, Japan. Electronic address: nagaseh@med.teikyo-u.ac.jp.
Zitieren
APA
Nagase, H. (2023). Rapid progress in molecular targeted therapy for allergic diseases. Allergology International. https://doi.org/10.1016/j.alit.2022.11.011
Vancouver
Nagase H. Rapid progress in molecular targeted therapy for allergic diseases. Allergology International. 2023. doi:10.1016/j.alit.2022.11.011
BibTeX
@article{Nagase2023,
author = {Nagase, Hiroyuki},
title = {Rapid progress in molecular targeted therapy for allergic diseases},
journal = {Allergology International},
year = {2023},
doi = {10.1016/j.alit.2022.11.011}
}
EUVIMED